PUBLISHER: Grand View Research | PRODUCT CODE: 1268817
PUBLISHER: Grand View Research | PRODUCT CODE: 1268817
The global animal antimicrobial and antibiotics market size is expected to reach USD 893.93 million by 2030, as per the new report by Grand View Research, Inc. The rise in zoonotic diseases, which are diseases that can be transmitted from animals to humans, has been a driving force behind the growth of the animal microbial and antibiotics market.
One of the primary causes of zoonotic disease transmission is the increased proximity of humans to animals, often because of urbanization and the expansion of agricultural and livestock operations. This increased contact can lead to the spread of diseases in animals, and may also create opportunities for the emergence of new and more virulent strains of pathogens.
Antibiotic resistance is one of the biggest challenges faced in the market growth. Overuse and misuse of antibiotics in animals and humans have led to the development of antibiotic-resistant bacteria, which can make it difficult to treat infections. According to WHO Report 2022, elevated levels of resistance in certain types of bacteria can lead to serious and potentially fatal bloodstream infections.
As the global population continues to grow, the demand for animal protein is increasing, which is driving growth in the animal health industry. However, there is growing concern about antibiotic resistance, which has created a need for the development of new antimicrobial agents that can effectively treat bacterial infections in animals without contributing to the development of resistance. Research into new classes of antibiotics and alternative therapies, such as bacteriophages and immunotherapies, could lead to the development of more effective and sustainable treatments that meet the needs of a growing animal protein market.